The leucine zipper transcription factors cAMP response element binding protein (CREB), cAMP response element modulatory protein (CREM) and activating transcription factor 1 (ATF1) bind to the cAMP response element (CRE) with the palindromic consensus sequence TGACGTCA. Their transcriptional activities are dependent on serine phosphorylation induced by various extracellular signals such as hormones, growth factors and neurotransmitters. Here we show that CREB is the predominant CRE-binding protein in Xenopus embryos and that it plays an essential role during early development. The importance of CREB for morphogenetic processes was assessed by injection of RNA encoding a dominant-negative form of CREB that is fused to a truncated progesterone receptor ligand binding domain. In this fusion protein, a dominant-negative function can be induced by application of the synthetic steroid RU486 at given developmental stages. The inhibition of CREB at blastula and early gastrula stages leads to severe posterior defects of the embryos re¯ected by strong spina bi®da, whereas the inhibition of CREB at the beginning of neurulation resulted in stunted embryos with microcephaly. In these embryos, initial induction of neural and mesodermal tissues is not dependent on CREB function, as genes such as Otx2, Krox20, Shh and MyoD are still expressed in injected embryos. But the expression domains of Otx2 and MyoD were found to be distorted re¯ecting the abnormal development in both neural and somitic derivatives. In summary, our data show that CREB is essential during several developmental stages of Xenopus embryogenesis. q
Introduction
cAMP response element binding protein (CREB), cAMP response element modulatory protein (CREM) and activating transcription factor 1 (ATF1) belong to the basic leucine zipper transcription factor family and comprise a subfamily sharing high sequence homology (for review see Hurst, 1995; Sassone-Corsi, 1995; Montminy, 1997) . They can form both homo-and heterodimers and bind to cAMP response element (CRE) with the sequence TGACGTCA (Ziff, 1990) . CREB which was initially identi®ed as the major factor mediating the transcriptional response to elevated levels of cAMP (Gonzalez et al., 1989 ) is activated by multiple kinase pathways. They all are controlled by cell membrane receptors that bind peptide hormones (Klemm et al., 1998) , growth factors (Finkbeiner et al., 1997) or neurotransmitters (Pende et al., 1997) . Upon activation of various intracellular signal transduction pathways, nuclear kinases such as cAMP-dependent protein kinase A (PKA) (Gonzalez and Montminy, 1989) , calmodulin-dependent kinase IV (Sun et al., 1994) , Ras-dependent protein kinase RSK2 (Xing et al., 1996) , p70 S6 kinase (de Groot et al., 1994) , MAPKAP kinase-2 (Tan et al., 1996) and mitogen-and stress-activated protein kinase-1 (Deak et al., 1998) are able to activate by phosphorylation of serine 133 in CREB or its conserved motifs in ATF1 and CREM. Dephosphorylation of the activated CREB by speci®c phosphatases is an additional regulation step to modulate CREB activity (Hagiwara et al., 1991; Nichols et al., 1992; Bito et al., 1996) . CREB-mediated transcriptional activation of target genes also requires co-activators such as CBP (CREB-binding protein) which binds to the phosphorylated form of CREB and contacts and stimulates the basal transcriptional machinery (Kwok et al., 1994) . CREB is present at various expression levels, but ubiquitously both in embryos and adult rodents (Lee and Masson, 1993; Imaki et al., 1994; Bleckmann and Schu Ètz, unpublished results) , implying multiple functional roles of CREB.
The CREB family is well conserved throughout evolution as it has been characterized in human, rodents, Drosophila (for review see Hurst, 1995) , Aplysia (Bartsch et al., 1995) , and hydra (Galliot et al., 1995) . Different CREB family members have been implicated in a variety of processes during embryonic development and in adult physiology (see below). Gene targeting experiments in mouse showed essential functions for CREB in the consolidation of longterm memory (Bourtchuladze et al., 1994) , in lung and T cell development (Rudolph et al., 1998) , and for CREM in male fertility (Blendy et al., 1996; Nantel et al., 1996) , but mice with ATF1 de®ciency are viable and do not display any obvious phenotype (Blendy and Schu Ètz, unpublished results) . In Drosophila, two CREB genes are known. Deletion of the dCREB-A gene leads to changes in the dorsoventral patterning of the larval cuticle (Andrew et al., 1997) , and dCREB-B gene is required for transcription of the Ultrabithorax gene in the endoderm (Eresh et al., 1997) . Tissuespeci®c overexpression of a dominant-negative form of CREB in mouse described functions of the CREB family in T cell differentiation (Barton et al., 1996) , in the regulation of growth hormone gene expression in the pituitary (Struthers et al., 1991) , and in function of cardiomyocytes (Fentzke et al., 1998) . Overexpression experiments in Drosophila and microinjection experiments in Aplysia showed that the CREB family is also essential for the consolidation of long-term memory in these invertebrate species (Dash et al., 1990; Yin et al., 1994; Yin et al., 1995) . Different CREB family members are also implicated in receptormediated induction of the c-fos gene (Peunova and Enlikolopov, 1993; Ginty et al., 1994) , in the regulation of genes encoding peptide hormones (Montminy et al., 1986) and in transcriptional responses to circadian rhythms (Ginty et al., 1993; Stehle et al., 1993; Foulkes et al., 1997) .
In an attempt to analyze the function of the CREB family in early vertebrate development, we used Xenopus as a model system. RNA encoding a dominant-negative form of CREB was injected into 4-cell stage embryos to block the action of all putative CREB family members, and the resulting phenotypic changes were analyzed. In addition, to assess CREB function at different developmental stages and to circumvent early lethality of embryos due to dysfunction of CREB family members, an inducible dominant-negative form of CREB was constructed. The injection experiments using the inducible dominant-negative CREB allowed us to demonstrate for the ®rst time that the CREB family is required at several stages during early Xenopus development, namely at blastula, gastrula and neurula stages.
Results

Expression of CREB proteins in Xenopus embryos
The presence of CREB proteins in Xenopus embryos was evidenced by bandshift experiments using whole cell extracts from stage 11 and stage 20 embryos. This method is very sensitive as, e.g. one quarter of a gastrula embryo was suf®cient to yield strong signals. The speci®city of the shifts was shown, both by competition with unlabeled CREoligonucleotide and by supershifts induced by various antibodies. Firstly, we performed band shift experiments using nuclear extracts from stage 20 embryos. Antisera against two CREB-speci®c epitopes (CREB LKDL , CREB KILN ) and an antiserum recognizing an epitope present both in CREB and ATF1 (ATF1.2) supershifted most of the CREbinding activity (Fig. 1A ). An antiserum that speci®cally recognizes ATF1 (ATF1.1), however, did not produce a Fig. 1 . Presence of CREB-like protein and CREB mRNA in Xenopus embryos. (A) Bandshift experiments using 32 P-labeled CRE oligonucleotides and stage 20 embryonic nuclear extracts show the presence of CRE-binding activity (lanes 1 and 2). Anti-CREB antibodies (lanes 3 and 4) and anti-phospho-CREB antibodies (lane 5) induced strong supershifts, but the antiserum ATF1.1 which is speci®c for ATF1 was unable to produce a supershift (lane 6). Antiserum ATF1.2 recognizing both CREB and ATF1 produced a strong supershift (lane 8). Adding a 100-fold excess of unlabeled CRE oligonucleotides completely abolished bandshift signal (lane 9). (B) Northern blot analysis showing a speci®c 2.6 kb band representing Xenopus CREB mRNA. supershifted band suggesting that either ATF1 is not present at detectable levels at these stages or that the antiserum did not recognize the Xenopus ATF1 epitope. The speci®city of the bandshifts was shown by incubation with preimmune serum resulting in a lack of a supershift (lane 2), and by addition of a 100-fold excess of unlabeled CRE, leading to a competition of the radiolabeled CRE-CREB complex (lane 9). We also performed bandshift experiments using stage 11 nuclear extracts and observed CREB-CRE complexes that could be supershifted with anti-CREB antibodies (data not shown). Taken together, these results indicate that CREB protein is expressed in Xenopus embryos.
Phosphorylation of CREB, CREM and ATF1 at a speci®c serine residue by protein kinases have been shown to be required for their transcriptional activation by extracellular signals (Finkbeiner et al., 1997; and references therein) . Phosphorylation of Xenopus CREB was demonstrated by the use of an antibody that speci®cally recognizes the phosphorylated form of CREB but not the unphosphorylated CREB. The strong supershift induced by the anti-phospho-CREB antibody (pCREB, lane 5 in Fig. 1A ) suggests the presence of activated signal transduction pathways in Xenopus embryos that lead to the phosphorylation of CREB/ CREM/ATF1 proteins and to concomitant CRE-mediated gene activation. Thus, it is conceivable to test whether the CREB/CREM/ATF1 family plays a role during Xenopus development.
The expression of CREB proteins during embryogenesis was further substantiated by Northern blot analysis by low stringency hybridization using the leucine zipper region of mouse CREB as a probe (Fig. 1B) . Only one mRNA species of 2.6 kb was detected at stage 10, indicating that at this stage only one member of the CREB/CREM/ATF1 family is predominantly present. In comparison, in mouse several splice forms of the CREB and CREM genes were characterized in tissues other than from embryonic origin (Foulkes et al., 1991; Blendy et al., 1996) . Together with the previous observation that antibodies speci®c for CREB induced a strong supershift, it argues that in Xenopus CREB is the major CRE-binding protein among the family members of CREB proteins.
Constitutive and inducible dominant-negative forms of CREB
A dominant-negative strategy has been applied to study the function of the CREB family proteins during Xenopus embryogenesis. The CREB protein can form dimers via its leucine zipper domain only with CREB, CREM and ATF1 (Foulkes et al., 1991; Rehfuss et al., 1991) . CREB mutated at serine 133 to an alanine (CREB A133 ) ( Fig. 2A) can still form dimers with endogenous CREB, CREM and ATF1, but cannot be activated by phosphorylation. These homo-or heterodimers, respectively, may bind to CREs, but they have much reduced transcriptional activation potency (Lonaux et al., 1994) . Thus, CREB A133 is a powerful tool to inactivate all three transcription factors CREB, CREM and ATF1. The constitutive dominant-negative CREB A133 has successfully been used in transgenic animals to inhibit endogenous CREB activity (Struthers et al., 1991; Yin et al., 1994; Barton et al., 1996; Fentzke et al., 1998) .
To be able to inactivate the CREB function at any given developmental stage, a fusion protein of rat CREB A133 and a truncated ligand binding domain of the human progesterone receptor was generated, resulting in CREB A133 PR (Fig. 2A) . The activity of this fusion protein is expected to be regulated by the synthetic steroid hormone RU486 (Wang et al., 1994; Kellendonk et al., 1996) . It is important to note that steroids endogenously present in vertebrates, such as progesterone, are however unable to activate the mutated progesterone receptor (Vegato et al., 1992; Wang et al., 1997 ). We have also tested whether RU486 might have any in¯uence on Xenopus development, but we did not observe any developmental alterations when embryos were continuously treated with 100 nM or 5 mM of RU486 from stage 7 to stage 40 (data not shown).
To test whether the dominant-negative effect of CREB A133 PR is dependent on RU486 administration, transient transfection experiments in F9 teratocarcinoma cells were performed (Fig. 2B ). The reporter construct consisted of the CRE-containing somatostatin promoter that is fused to the indicator gene chloramphenicolacetyltransferase (Montminy et al., 1986) . Transcriptional activity is represented as percentage of the maximal activation when wildtype CREB is transfected (lane 3). The addition of RU486 had no effect on the transcriptional activation by CREB (lane 4). Increasing amounts of CREB A133 PR (2.5 and 5 mg of DNA) were then cotransfected with a constant amount of wild-type CREB into cells (lanes 5±8). In the absence of RU486, stimulation of transcription was similar as with wild-type CREB (compare lanes 5 and 7 with lane 3). After addition of RU486, repression of wild-type CREB is observed, as expected. Thus, the function of endogenous CREB can be attenuated by expression of CREB A133 PR and simultaneous application of RU486.
We furthermore investigated the stability of the CREB A133 PR fusion protein in Xenopus embryos (Fig.  2C ). RNA (750 pg/blastomere) encoding the CREB A133 PR protein was injected equatorially into all blastomeres at the 4-cell stage, embryos were then incubated to stages 8, 10 and 12 in the absence of RU486, and whole cell extracts were prepared. Western blot analysis using a CREB-speci®c antiserum (anti-CREB KILN ) revealed a band of the expected size of about 60 kDa in lysates from all stages analyzed, representing the CREB A133 PR fusion protein (lanes 4±6). Such a band is absent in lysates from uninjected embryos (lanes 1±3) providing evidence for the speci®city of the detected signal as the CREB A133 PR fusion protein. Importantly, the CREB A133 PR protein is present in stage 12 embryos at levels comparable to those observed at stage 8 and stage 10. Thus, the stability of the CREB A133 PR protein enables us to inhibit CREB function by adding RU486 to embryos as late as stage 12.
Phenotypic changes upon inhibition of CREB/CREM/ ATF1 function in Xenopus embryos
In a ®rst set of experiments, RNA encoding the constitutive dominant-negative CREB A133 was injected equatorially into every blastomere of 4-cell stage embryos, and embryos were incubated to stage 40. Dose-dependent morphological changes were observed (Table 1) . At a low dose of RNA injected (25 pg RNA per blastomere), 60% of the embryos displayed strong spina bi®da, whereas at a dose of 150 pg per blastomere, 100% of the embryos had gastrulation defects such as spina bi®da. At both concentrations, no morphological changes could be observed up to the beginning of gastrulation (stage 10). But at later stages, CREB appears to be required for the progression of gastrulation. When RNA coding for wild-type CREB was injected at a dose of 150 pg per blastomere, no phenotypic changes were observed (data not shown).
To determine the period during early Xenopus development when CREB function is required (Fig. 3) we injected RNA coding for CREB A133 PR equatorially into every blastomere at the 4-cell stage (750 pg/blastomere). At stages 8, 10, and 12, respectively, RU486 was added to the modi®ed Barth solution at a concentration of 1 mM to activate the inhibitory function of CREB A133 PR, and embryos were incubated in the continuous presence of RU486 until stage 40. Injected embryos incubated in the absence of RU486 displayed no morphological changes (see Fig. 4 , right panel). Thus, the inhibitory function of CREB A133 PR is strictly dependent on the activation by RU486 as it was observed in transfection experiments in cell culture (Fig.  2B ). The degree of malformations observed was dependent on the time point of RU486 application (Fig. 4, Table 1 ). When RU486 inductions were at stage 8 or stage 10, respectively, the phenotypes were very severe and similar to each other and have also some similarities to those caused by injection of a low dose of RNA encoding the constitutive dominant-negative CREB A133 (25 pg/blastomere). The embryos displayed strong posterior truncations and spina bi®da. Based on the presence of structures such as cement gland, eyes and trunk, the histological landmarks of the gross anteroposterior organization of the embryo were still present, but their spatial arrangement was severely perturbed. When RU486 was applied at stage 12, the phenotype was milder. The embryos were stunted, curved and displayed very frequently microcephaly, but no spina bi®da (Fig. 4, Table 1 ). This milder phenotype is not due to the lack of CREB A133 PR protein in the embryo at the time of RU486 induction (i.e. at stage 12), since CREB A133 PR is present in the embryo at comparable amounts at stages 8, 10 and 12 (Fig. 2C) . Histological transverse sections through injected embryos furthermore revealed the presence of all major embryonic tissue types (Fig. 5 ): Neural tissue (brain, eyes, otic vesicle, spinal cord with¯oorplate), mesoderm (notochord, somites, pronephros) and endoderm (gut) were present, however the morphology of structures such as of neural tissue, gut and somites (Fig. 5 , see also in Fig. 6 , MyoD expression domain) was abnormal. Frequently, some excessive neural tissue, for example in the hindbrain, can be observed (Fig. 5B,C,D) , whereas the amount of mesodermal and endodermal tissue appears to be slightly reduced (compare Fig. 5A and C).
To provide evidence that the observed phenotypes were caused directly by the dominant-negative CREB and were not due to the sequestration of factors of the transcriptional machinery by the amino terminal part of CREB A133 PR, a truncated form CREBD A133 PR was injected ( Fig. 2A) . This leucine zipper mutant is not able to form dimers, cannot bind to DNA (Dwarki et al., 1990) and is, therefore, expected to be devoid of its inhibitory activity. Consistent with this notion, we did not observe any morphological changes in CREBD A133 PR injected embryos after RU486 treatment at stage 8 (Table 1) . This control experiment clearly demonstrates that the phenotypes observed after CREB A133 PR injection and concomitant RU486 treatment were caused by speci®c inhibition of the CREB-mediated signal transduction pathways.
To de®ne the germ layers in which CREB function might be essential for proper development, constitutive dominantnegative CREB A133 was injected either equatorially into all blastomeres at the 4-cell stage or into animal pole cells at the 8-cell stage. We observed that equatorial injections were most effective and that animal pole cell injections resulted either in slightly stunted embryos, comparable to those observed in embryos injected equatorially with the inducible dominant-negative CREB A133 PR and induced with RU486 at stage 12, or even in a lack of phenotypic changes (data not shown). This suggests that the defects might occur mainly in mesodermal derived tissues. This notion is consistent with animal cap assays we performed with the constitutive dominant-negative CREB A133 . When animal caps from stage 8 are incubated with activin, mesoderm can be induced without endogenous mesoderm inducers as shown by others (Smith, 1993) . Concomitant with the induction of mesoderm-speci®c markers such as the Brachyury gene and the gene for muscle actin, activin-treated animal caps elongated (Smith, 1993) . When animal caps from embryos injected equatorially with CREB A133 were incubated with activin from stage 8 on continuously, no typical activininduced elongation was observed. RT±PCR analysis of such animal caps, however, showed the presence of the Fig. 4 . Inhibition of CREB function leads to phenotypic changes of developing Xenopus embryos. All blastomeres of 4-cell stage embryos were injected equatorially with CREB A133 PR mRNA (750 pg each), and embryos were treated with 1 mM RU486 at the stages indicated and were cultured until stage 40. Treatment at stage 8 resulted in strong spina bi®da and shortening of the anteroposterior extension, whereas treatment at stage 12 led to stunted embryos with microcephaly. Injected embryos without RU486 treatment developed normally. Scale bar: 500 mm. mesoderm markers such as Brachyury and muscle actin mRNA (data not shown). From these experiments, we concluded that CREB might not be required for the initial speci®cation of mesoderm, but rather for proper morphology of mesodermal structures such as somites.
As genes involved in apoptosis, e.g. bcl-2 (Wilson et al., 1996) and in cell cycle control, e.g. cyclin A (Desdouets et al., 1995) contain CREs as regulatory elements in their promoters, we determined both apoptosis by in situ TUNEL experiments and rate of proliferation by bromodeoxyuridine incorporation in injected embryos that were RU486-treated at stage 12. However, we could not detect statistically significant differences in apoptosis nor proliferation rates between induced and uninduced embryos (data not shown).
Marker gene analyses
In an effort to understand the mechanisms leading to the observed morphological changes, we analyzed the expression of speci®c marker genes in stage 30 albino embryos that were injected with dominant-negative CREB A133 PR at the 4-cell stage and that were then continuously treated with RU486 from stage 12 to stage 30 in order to get insights into the mechanism of the late phenotypes. Control embryos were injected with RNA encoding CREB A133 PR, but not treated with RU486. The morphology observed was equivalent to that shown in Fig. 4 and Table 1. The expression of marker genes was analyzed by whole mount in situ hybridization to de®ne the abnormal development at the molecular level (Fig. 6) .
The characteristics of the neural tissue along the anteroposterior axis were investigated with three marker genes, Xanf1, Otx2 and Krox20. Xanf1 (Zaraisky et al., 1992; Gawantka et al., 1998) , a homeobox-containing gene with highest homology (54%) to the homeobox of Mix.1 (Rosa, 1989) , is expressed in the pituitary at stage 30, a structure considered to be at the very anterior end of the neurectoderm. From six injected embryos analyzed by whole mount in situ hybridization, four embryos showed Xanf1 expression in the pituitary, but two embryos lacked Xanf1 expression (data not shown), showing that anterior truncations of the head structures occurred at low frequency when CREB function is impaired. Otx2, a vertebrate homologue of the Drosophila orthodenticle gene (Simeone et al., 1993) , is shown to be a central factor in patterning the forebrain. At stage 30, it displays three major expression domains; in the telencephalon, in the mesencephalon and in the retina (Blitz and Cho, 1995; Kablar et al., 1996) . In comparison to control embryos, in which the expression domains in the telencephalon and the mesencephalon were well separated from each other, telencephalic and mesencephalic expression domains were poorly separated from each other in CREB A133 PR/RU486-treated embryos at stage 30 (Fig. 6 , middle and lowest row). This could be due to a delayed or even lack of down-regulation of the diencephalic expression domain in CREB A133 PR/RU486-treated embryos, as foreand midbrain expression domains are contiguous in wildtype embryos prior to stage 28 and were then separated by stage 30. The expression in the retina appears to be unaffected in embryos with impaired CREB function. Patterning of the hindbrain was unaffected in treated embryos as expression domains of Krox20, a marker for rhombomere 3 and 5, were consistently unchanged in all injected embryos, showing a strong expression in rhombomere 5 and a weaker expression in rhombomere 3 (data not shown).
CREB is a transcription factor that is regulated, among other kinases, by PKA. We thus wanted to test the hypothesis whether CREB might be involved in mediating the sonic hedgehog (SHH) signal transduction pathway. It has been shown in Drosophila and in vertebrates that PKA, activated by increased intracellular cAMP concentration, inhibits the SHH-mediated signal (for review see Hammerschmidt et al., 1997) . Inhibition of PKA function by injecting RNA encoding a dominant-negative PKA into zebra®sh blastoderm stage embryos resulted in an extension of ventral midline identity, i.e. expansion of ventral fates in the brain and adaxial fates in somites indicating an overexpression or higher activity of SHH (Hammerschmidt et al., 1996) . If CREB were to function in the SHH-mediated signal transduction pathway, injection of dominant-negative CREB might increase SHH-mediated activity leading to a similar phenotype as observed with dominant-negative PKA. We ®rst analyzed the expression of Shh by whole mount in situ hybridization, but we found that Shh expression was not changed after inhibition of CREB function (Fig. 6 ). However, a mesodermal target of Shh, MyoD, was altered. Its expression domains were clearly present, but the somites did not display their typical chevron-like structure, rather the MyoD expression domain in the somites was split into a dorsal and a ventral domain (Fig. 6) . Thus, an interruption of the CREB pathway interferes more likely with proper patterning of somite subregions leading to an abnormal somite morphology than with a distinct control of the marker genes tested.
Discussion
Using bandshift experiments and Northern blot analysis we showed that CREB is expressed in gastrula and neurula stages of Xenopus development. Moreover, the phosphorylated and thus activated form of CREB is also expressed in these stages. By injection of dominant-negative forms of CREB into Xenopus blastomeres, we were able to show that CREB is required for gastrulation and for processes during neurulation stages. To de®ne the temporal window when CREB is required for developmental processes, we constructed an inducible dominant-negative form of CREB. This was achieved by fusing the mutant form of CREB (CREB A133 ) to a mutated ligand binding domain of the progesterone receptor. The activity of the resulting fusion protein can be regulated by the synthetic steroid hormone RU486. We could show here that this inducible system is well-suited for experiments in Xenopus, as (1) RU486 has no side effects on early embryogenesis, (2) the activity of the fusion protein can be regulated very tightly, (3) it is feasible to ®nd an optimal concentration for RNA injections where the system is not leaky without RU486, but a phenotype is inducible by RU486 application, and (4) the fusion protein is stable until stage 12. Moreover, there is the possibility to combine the RU486-inducible system with the tamoxifen-inducible system described by others in mammals Feil et al., 1997) . This would enable to independently regulate the activity of two different proteins at a given time schedule. A dexamethasone-inducible system (Kolm and Sive, 1995) has recently been applied in Xenopus to de®ne Otx2 target genes (Gammill and Sive, 1997) . By using the inducible dominant-negative form of CREB, we could show that CREB is not essential for mid-blastula transition nor for initiation of gastrulation, as size and morphology of injected embryos that were induced with RU486 at stage 8 appeared to be normal at stage 10. Consistent with this is the observation that the phenotype of embryos injected with the constitutive dominant-negative CREB A133 resulted in a similar phenotype as the embryos injected with CREB A133 PR and RU486-induced at stage 8. However, our experiments showed that CREB is essential for proper somite and neural tube morphogenesis. Regarding mesoderm development, we observed in animal cap assays that activin-induced elongation is inhibited by dominant-negative CREB. All mesodermal markers analyzed were expressed at levels comparable to uninjected animal caps, but somites are nevertheless misshapen. On histological sections, it appears that the amount of somitic tissue is slightly reduced. Thus, CREB is not required for initial mesoderm induction, but it is clearly essential for the establishment of proper somite morphology, suggesting that CREB might function in the regulation of cell-cell contacts. Similarly, endoderm and neurectoderm are present in injected embryos, but again morphology of these structures are misshapen, as shown by histological analysis. Moreover, in situ hybridization experiments with probes for genes that are implicated in anteroposterior (Xanf1, Otx2, Krox20) and dorsoventral patterning (Shh, MyoD), showed the presence of these genes, but their proper spatial arrangements were affected, particularly well visible for Otx2 and MyoD. Again, CREB is not required for the initial establishment of these polarities of the embryo, but for the proper establishment of the expression domains.
In injected embryos that were treated with RU486 at stage 12, we frequently observed stunted appearance, misshapened neural tissues and somites. In this context, it is interesting to note some similarities of the phenotype in mice carrying mutations in the transcriptional coactivators CBP and p300 that are implicated in the transcriptional activation of target genes by phospho-CREB. Both null mutants for p300 as well as compound-heterozygous mutants for p300 and CBP display stunted appearance, open neural tube in the cranial region, abnormal mass of neural tissue in ventricles, kinked neural tube and disorganized somites (Yao et al., 1998) .
Our dominant-negative approach was aimed to inhibit the activity of CREB. We were able to show in Xenopus that CREB begins to be required from gastrula stages on. It is interesting to relate this ®nding with observations in mice that carry mutations in the CREB and ATF1 genes. While the CREB null mutation is perinatal lethal due to delayed lung development (Rudolph et al., 1998) and ATF1 mutant mice are fully viable (Blendy and Schu Ètz, unpublished results) , double-mutants for CREB and ATF1 display lethality prior to implantation (Bleckmann and Schu Ètz, unpublished results) . Two explanations can be put forward to relate these ®ndings. Firstly, there might be additional processes in early development in which murine CREB function is required, e.g. for the formation of blastocysts that consist of inner cell mass and trophoblast cells or for the process of implantation. Secondly, it is also possible that our dominant-negative approach did not achieve complete inhibition of CREB-mediated gene activation, and thus, we observed a distinct, but milder phenotype in Xenopus than in mice double-mutated in the CREB and ATF1 genes.
In summary, inhibiting CREB function leads to a defect in gastrulation as evident in the development of spina bi®da and to a defect in somitogenesis. However, it does not interfere with the establishment of the ground state of axes and germ layers. Furthermore, anteroposterior patterning of the brain is disturbed, as it is evident from an ectopic expression of Otx2 in the diencephalon, which suggests that the foreand midbrain domains do not separate properly. Thus, CREB appears to be required for proper spatial arrangement of muscle precursor domains (myotomes) and for the establishment or maintenance of distinct subregions during brain morphogenesis.
Experimental procedures
Band shift experiments
Whole cell extracts were prepared from 25 to 40 stage 11 and stage 20 Xenopus embryos by sonication on ice in 400 ml extraction buffer (25 mM Tris±HCl pH 8.0 containing 0.4 M NaCl, 5 mM DTT, 1 mM EDTA, 1 mM Pefabloc (Boehringer), 1 mM sodium vanadate, 10 nM calyculin, 20% glycerol) and centrifugation for 10 min at 100 000 rpm (Beckman TL-l00 Ultracentrifuge). Protein concentration was determined by BCA assay (Pierce) and was about 5 mg/ml. In a total volume of 10 ml, 2 ml of whole cell extract was incubated on ice in a mixture containing 5 fmol 32 Plabeled somatostatin CRE as previously described (Nichols et al., 1992) and 0.25 mg of calf thymus DNA as non-speci®c competitor. Supershifts were generated by addition of 1 ml of af®nity puri®ed antibodies directed against the following epitopes: phospho-CREB (Ser 133 phosphorylated peptide 123-KRREILSRRPS133YRK-136) (Iordanov et al., 1997) , CREB KILN (peptide 136-KILNDLSSDAPGV-PRIEEEK-156) (Nichols et al., 1992) , CREB LKDL (peptide 132-LKDLYCHKSD-141), mATF1.1 (peptide 10-TETASQPGSTVAGPHVSQIVHQVSSL-35), mATF-1.2 (170- . Production and puri®cation of anti-CREB LKDL , anti-mATF1.1, and antimATF1.2 was performed as previously described (Nichols et al., 1992) . Samples were analyzed on non-denaturing 5% polyacrylamide gels in 0:3£ TBE. Gels were dried onto Whatman 3MM paper and exposed to Kodak X-OMAT ®lm with intensifying screen at 2808C.
Northern blot analysis
Northern blot analysis was performed as previously described (Gawantka et al., 1995) . In brief, 2 mg of stage 10 polyA 1 RNA were separated on a 1.2% formaldehyde gel (Sambrook et al., 1989) and transferred onto a GeneScreen membrane (DuPont). As a hybridization probe, a 32 Plabeled random-primed 300 bp RsaI-XhoI fragment from RSV-CREB was used (Gonzalez and Montminy, 1989) . This fragment contains exon 10 and 11 and includes the DNA-binding domain and the leucine zipper. Prehybridization and hybridization were performed at 588C, and low stringency washes were at 558C in 2£ SSPE (Sambrook et al., 1989) and 0.5% SDS three times for 20 min. Filters were exposed to Kodak X-OMAT ®lm with intensifying screen at 2808C for overnight.
Plasmid construction
CREB A133 PR fusion was generated by overlap PCR (Horton et al., 1989) . The rat CREB A133 was ampli®ed from RSV-CREBM1 (Gonzalez and Montminy, 1989) with oligomer A (AGT AAT AGA TCT GAA AGC AGT GAC TGA GGA G) and oligomer B (GAA CTT TTT ATC TGA CTT GTG GCA GTA AAG). The mutated human progesterone receptor ligand-binding domain of hPR891 (Vegato et al., 1992) was ampli®ed from pGLVP (Wang et al., 1994) with oligomer C (CAC AAG TCA GAT AAA AAG TTC AAT AAA GTC AGA G) and oligomer D (CGG CTC GAG CTC TAG AGT CAG CAG TAC AGA TGA AGT TGT). Both PCR fragments were puri®ed and then used for the fusion PCR with oligomer A and oligomer D. Puri®ed fragments were cut with BglII and XhoI and cloned into the expression vector pHD2K which has been modi®ed from pHD2 (Weih and Schu Ètz, unpublished) by a KpnI cut, ®ll-in reaction and religation to remove the unique KpnI site. The resulting pHD-CREB A133 PR was used for transfection experiments. The integrity of the PCR product was con®rmed by sequencing. The whole insert was subsequently cloned into pRN3 (Lemaire, unpublished). The resulting pRN-CREB A133 PR was used for RNA injection experiments in Xenopus embryos. For the construction of pRN-CREBD A133 PR, PCR reactions were performed with oligomer A and oligomer E (GAA CTT TTT CCT GTT CTT CAT TAG ACG AAC) with RSV-CREBM1 as the template, and with oligomer F (ATG AAG AAC AGG AAA AAG TTC AAT AAA GTC AGA G) and oligomer D with pGLVP as the template. The fusion fragment was generated with oligomer A and oligomer D in the presence of the puri®ed PCR fragments. The resulting fragment was cut with Asp718 and HindIII and was cloned into pRN-CREB A133 PR cut with Asp718 and HindIII. For con®rma-tion, the PCR-ampli®ed region was sequenced. From RSV-CREB and RSV-CREBMl (Gonzalez and Montminy, 1989) , the EcoRI-DraI fragments were cloned into pBSII KS(2) cut with EcoRI and HindIII. From the resulting constructs, the SmaI-XhoI fragments were cloned into pHD2K cut with SmaI and XhoI. The resulting clones were designated as pHD-CREB and pHD-CREB A133 , respectively. From RSV-CREB and RSV-CREBMl, the EcoRI-DraI fragments were cloned into pBS KS(1) cut with EcoRI and SmaI. From the resulting constructs, the EcoRI-NotI fragments were cloned into pRN3 cut with NotI and EcoRI. The clones were named pRN-CREB and pRN-CREB A133 , respectively.
Transfection
Mouse F9 teratocarcinoma cells were cultured and transfected as previously described (Ruppert et al., 1992; Blendy et al., 1996) . In brief, 1.2 £ 10 6 cells were plated onto 60-mm culture dishes and transfected 3 h later with calcium phosphate-DNA co-precipitates. All dishes received 1 mg of (271)somatostatin-CAT as the reporter (Montminy et al., 1986) , 1 mg of CEV (Uhler and McKnight, 1987) , 0.5 mg of RSV-luciferase for standardization (de Wet et al., 1987) , and 2.5±5 mg of pHD-CREB and pHD-CREB A133 PR. The amount of DNA was adjusted to 10 mg for one dish with pHDmBERC (Ruppert et al., 1992) . The medium was changed after 20 h, and cells were harvested after another 24 h of incubation. CAT extracts were prepared and analyzed as described (Neumann et al., 1987) .
Microinjection experiments
The plasmids pRN-CREB, pRN-CREB A133 , pRN-CREB A133 PR and pRN-CREBD A133 PR, respectively, were linearized with S®I, and transcriptions with T3 RNA polymerase were performed as previously described (Gawantka et al., 1995) . Microinjections were performed into the equatorial region of all four blastomeres of 4-cell stage embryos (5 nl/injection). The concentrations of RNA were 5 or 25 ng/ ml for CREB A133 , and 140 ng/ml for CREB A133 PR. Embryos were incubated in l£ Barth solution containing 2 U/ml penicillin, 2 mg/ml streptomycin and 1 mg/ml BSA. In induction experiments, RU486 was added to a ®nal concentration of 1 mM from a 10 000£ stock solution containing 100% ethanol.
Western blot analysis
Twelve embryos were extracted with 300 ml RIPA (400 mM NaCl, 1 mM CaCl 2 , 50 mM Tris±HCl pH 7.4, 0.1% SDS, 0.5% sodium deoxycholate, 1 mM Pefabloc from Boehringer). After sonicating 5£ for 1 s, insoluble material was cleared by centrifugation in a Beckman TL-100 Ultracentrifuge (100 000 rpm, 15 min, 48C). Equal volumes of 2£ loading buffer (Sambrook et al., 1989 ) was added to the supernatant, boiled for 5 min, and 50 ml (the equivalent of two embryos) were separated on a 10% SDS±PAGE. Blotting and detection of the fusion protein was performed as previously described (Iordanov et al., 1997) using the anti-CREB KILN antibody and the enhanced chemiluminescence method (Amersham). Ponceau S-stained gel indicated equivalent loading in all lanes (not shown).
Whole mount in situ hybridization and histology
Whole mount in situ hybridization was performed according to Gawantka et al. (1995) . The following probes were used: Xshh clone AX32 was linearized with BamHI and transcribed with T3 RNA polymerase (Ekker et al., 1995) , MyoD clone pSP-XMyoD2-24/3 was linearized with PvuII and transcribed with SP6 RNA polymerase (Hopwood et al., 1989) , and Krox20 clone Bs.EP400 was linearized with EcoRI and transcribed with T3 RNA polymerase (Wilkinson, personal communication) . Probes for Xanf1 (clone 5E2), Otx2 (clone 32E7.2) were generated as described in Gawantka et al. (1998) . Histological analysis was carried out as described (Gawantka et al., 1995) .
